Beyond Glucose: The Immunologic Architecture of Obesity and Type 2 Diabetes-Panel 1

Video Transcription

Video Summary

The panel “Beyond Glucose: The Immunologic Architecture of Obesity and Type 2 Diabetes” explores how obesity-related inflammation drives metabolic disease. The speakers explain that adipose tissue is not just fat storage, but an active immune and endocrine organ. In obesity, immune cells such as macrophages, T cells, B cells, and others infiltrate fat tissue and release inflammatory cytokines like TNF-alpha, IL-6, and IL-1 beta, which interfere with insulin signaling.  <br /><br />They describe how inflammation begins in adipose tissue but can spread systemically in humans, affecting the liver, skeletal muscle, and pancreatic islets. This contributes to fatty liver disease, fibrosis, insulin resistance, beta-cell dysfunction, and eventual type 2 diabetes. The discussion also highlights links between obesity and other inflammatory conditions, including osteoarthritis, psoriatic arthritis, asthma, and possibly autoimmune disease.  <br /><br />A major theme is the difference between animal models and human disease. Mouse studies have been foundational, but they do not fully match human biology, making clinical translation challenging. The panel concludes that inflammation changes over time as obesity progresses, suggesting that earlier intervention may be more effective than treating established disease.

Keywords

obesity

type 2 diabetes

inflammation

adipose tissue

insulin resistance

immune cells

cytokines